Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion type Assertion NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_head.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion description "[Cyclin D1 overexpression was seen in hyperplasia and metaplasia (6%), mild dysplasia (17%), moderate dysplasia (46%), and CIS (38%) in patients with cancer but was lost in 5% of the patients during the process of invasion; it was also observed in patients with no cancer progression (14%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_provenance.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion evidence source_evidence_literature NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_provenance.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion SIO_000772 10037171 NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_provenance.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion wasDerivedFrom befree-20140225 NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_provenance.
- NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_assertion wasGeneratedBy ECO_0000203 NP521069.RAZK9azt-_C6yqp89nDn7UhA-AP1GnOK9u-zwo4pO0Gag130_provenance.